Bayer Shops For More Schering AG Shares Outside Of Takeover Bid
This article was originally published in The Pink Sheet Daily
Executive Summary
Bayer may buy shares above original €86 offer price ahead of its June 14 deadline to acquire 75% of Schering.
You may also be interested in...
Bayer Continues Schering Takeover Bid After Rival Merck Bolsters Holdings
Merck KgaA increased its stake in Schering AG to 10.1% ahead of a June 14 deadline for shareholders to accept Bayer’s takeover offer.
Bayer Purchase Of Schering AG Would Give Firm Focus On Specialty Pharma
$19. 5 bil. offer by Bayer will likely thwart hostile takeover of Schering by Merck KgaA.
Future BIO Global Efforts Include International Relations, Greenwood Says
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13